Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y019464 | — |
No additional AE.; HCP calling to report that 1 year old patient received less than the desired dose of PROQUAD on 4/7/2025. Caller states patient received approximately about 0.1 ml due to human error. No adverse effects reported. No other information provided. Confir; This spontaneous report was received from an other health professional and refers to a(n) 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-APR-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection, lot #Y019464, expiration date: 24-MAY-2026 for prophylaxis (exact dose, dose number, route and site of administration were not provided). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided). The patient received less than the desired dose of PROQUAD. Caller states patient received approximately about 0.1 ml due to human error (accidental underdose). No adverse effects reported (no adverse event).
Sterile diluent